浙江大学医学院博士研究生导师简介：谢幸

　　32.Fu YF, Ye DF , Chen HZ, Lu WG , Ye F, Xie X .Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.Gynecol Oncol 2007;105 (1): 66-73

　　33.Ying W ,Li Y , Zhou Y, Xie X .Cyst distortion: a new sonographic sign of peritoneal pseudocyst with regular morphology. Ultrasound in Obstetrics & Gynecology 2007 29 (2): 240-241

　　34.Zhang JP, Lu WG, Ye F, Chen HZ, Zhou CY, Xie X. Study on CXCR4/SDF-1 alpha axis in lymph node metastasis of cervical squamous cell carcinoma. Int J Gynecol Cancer 2007 17(2): 478-483

　　35.Chen H , Ye F, Zhang J, Lu W , Cheng Q ,Xie X.Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma. Eur J Gynecol Oncol 2007 28 (6): 464-467

　　36.Liu J , Ye F, Chen H , Lu W , Zhou C , Xie X .Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors. Int J Gynecol Cancer 2007;17 (6): 1293-1299

　　37.Ye F, Chen H, Liang Z, Lu W, Cheng Q, Xie X. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice. Eur J Gynaecol Oncol 2006; 27(6):566-572

　　38.Huang JY, Ye F, Chen HZ, Xing X. Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma. Carcinogenesis 2007; 28(6):1314-1322

　　39.Zhang M, Holman CD, Huang JP, Xie X. Green tea and the prevention of breast cancer: a case-control study in southeast China. Carcinogenesis 2007 ; 28(5):1074-1078

　　40.Li X,Ye F, Chen HZ, Xie X. Human ovarian carcinoma cells generate CD4(+)CD(25+)regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta. Cancer Letters 2007; 253(1):144-153

　　41.Lin K ,Ye D,Xie X .Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer. Inter J Gynecol Cancer 2008;18 (5): 1007-1012

　　42.Ye F ,Hu Y, Lu W , Zhou C,Xie X. Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics. Histopathology 2008; 53 (2): 224-228

　　43.Ma YX , Ye F , Lu WG, Cheng Q, Chen HZ , Xie X. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma. European J of Obstetrics Gynecology and Reproductive Biology 2008;138 (2): 204-211

　　44.Zhang D ,Ding Z ,Qian J ,Xie X, Wang Y.Two rare cases of methotrexate-induced pneumonitis and pleurisy in patients with gestational trophoblastic neoplasms. European J of Gynecological Oncology 2008;29 (4): 390-392

　　45.Ye F , Zhang SF, Xie X, Lu WG.OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma. Cancer Inves 2008;26 (6): 569-574

　　46.Luo J, Qian JH, Yu JK , Zheng S , Xie X , Lu WG .Discovery of altered protein profiles in epithelial ovarian carcinogenesis by SELDI mass spectrometry. European J of Gynecological Oncology 2008;29 (3): 233-238

　　47.Lu WG,Ye F, Shen YM , Fu YF, Chen HZ , Wan XY, Xie X. EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. Int J Gynecol Cancer 2008;18 (2): 357-362

　　48.Chen YX , Xu J, Lu WG , Xie X. Primary ovarian choriocarcinoma mimicking ectopic pregnancy managed with laparoscopy - case report . European J of Gynecological Oncology 2008; 29 (2): 174-176

　　49.Hong D,Ye F,Chen H, Lu W, Cheng Q, Hu Y, Xing X .Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province,China. International Journal of Gynecological Cancer 2008;18(1):104-109

　　50.Mao YY,Wan XY, Chen YX, Xing X.Evaluation of the accuracy of intraoperative gross examination for the surgical management of endometrial cancer. European J of Obstetrics Gynecology and Reproductive Biology 2008;141(2):179-182

　　51.Hong D,Ye F, Lu WG, Xing X.Methylation status of the long control region of HPV 16 in clinical cervical specimens. Molecular Medicine Reports 2008;1(4):555-560

　　52.Hong D, Lu W,Ye F, Hu Y, Xing X.Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells. British J of Cancer 2009,101(10):1798-1804

　　53.Chen W,Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, Schmidt JE, Wang P,Liu YL, Li LK, Xing X et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.Cancer Causes & Control 2009;20(9):1705-1713

　　54.Wang XY, Pan ZM, Chen XD, Xie X. Accuracy of tumor grade by preoperative curettage and associated clinicopathologic factors in clinical stage I endometriod adenocarcinoma. Chinese Medical Journal 2009; 122(16):1843-1846

　　55.Tian QF, Lu WG,Chen HZ, Ye F, Xing X. The Nonsynonymous Single-Nucleotide Polymorphisms in Codon 31 of p21 Gene and the Susceptibility to cervical cancer in Chinese women. International J of Gynecological Cancer.2009, 19(6):1011-1014

　　56.Cheng XD, Lu WG,Ye F,Wan XY, Xie X.The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J of Experimental &Clinincal Cancer Research.2009; 28:91

　　57.Hu Y, Ye F,Lu WG,Xing X. HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells. Cancer Investigation 2009; 27(3):298-306

　　58.Chen LL, Ye F, Lu W, Hong D, Wan X, Xing X. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma. J of Obstetrics and Gynecology Research. 2009;35(2):212-218

　　59.Zhao XF, Ye F, Chen LL, Lu W, Xing X. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+naive T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro. Cancer Science 2009; 100(11):2143-2151

　　60.Cheng B, Lu W, Xiaoyun W, YaXia C, Xie X. Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases. International J of Gynecological Cancer 2009; 19(4):611-614

　　61.Cheng B, Wan XY, Qian X, Lv W, Xing X. Results of conservative surgery for recurrent borderline ovarian tumors. European J of Gynaecological oncology 2009; 112(1):199-204

　　62.Chen LL,Ye F, Xing X. Ovarian carcinoma cells influence differentiation of Lin-CD45RA-dendritic cell precursors into two mature subtypes in vitro. Gynocologic Oncology 2009;112(1):199-204

　　63. Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women.Int J Cancer . 2009;15;124(6):1404-8.

　　64.Chen Y, Lu H,Wan WY,Xie X. Factors associated with postive margins in patients with cervical intraepithelial neoplasia grade and postcinization management. Int J Gynaecol Obstet, 2009;107(2):107-10

　　65.Wang X, Lu W, Zhu C,Ye F,Xie X. Adenoid cystic carcinoma of Bartholin’s gland with lung metastasis:a case report. Eur J Gynecol Oncol. 2009;30(3):317-20

　　66.Li Y, Ye F,Hu Y, L v W, Xie X. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time PCR. Anal Biochem. 2009; 394(1):110-6

　　67.Chen H, Chen X, Ye F, Lu W, Xie X. Symmetric devision and expression of its regulatory gene Numb in human cervical squamous carcinoma cells. Pathobiology. 2009;76(3):149-54

　　荣誉和奖项: 获“浙江省优秀院长”称号，澳大利亚西澳大学“Raine杰出访问教授”。

　　作为负责人获部省级科技成果奖6项和国家发明专利1项。

　　1、教育部提名国家科技进步二等奖(2004年)：白介素-2和白介素-7基因转染卵巢癌细胞的体外研究。

　　2、教育部提名国家科技进步一等奖(2005年)：上皮性卵巢癌腹腔局部免疫缺陷机制的研究。

　　3、浙江省科技厅2006、2008年科学技术二等奖。

　　主编或参编专著和教材：担任人民卫生出版社国家规划教材《妇产科学》专升本教材主编、5年制教材副主编、长学制教材编者。并担任《International Journal of Biomedical Science》、《中华医学杂志(英文版)》、《中华医学杂志》、《中华妇产科杂志》、《中国实用妇科与产科杂志》、《现代妇产科进展》、《实用妇产科杂志》、《浙江大学学报(医学报)》、《浙江医学》、《实用肿瘤杂志》和《国际妇产科杂志》等国内外杂志的副主编、常务编委和编委，是《Carcinogenesis》、《Cancer Letters》、《Gynecol Oncol》和《Int J Gynecol Cancer》等国际著名SCI收录期刊的审稿专家。